|
T1476 |
Pramipexole
|
SND 919 |
Dopamine Receptor
|
|
Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not... |
|
T6951 |
Pramipexole dihydrochloride hydrate
|
Pramipexole 2HCl Monohydrate,Mirapex |
Dopamine Receptor
|
|
Pramipexole dihydrochloride hydrate (Mirapex) is the hydrochloride salt of pramipexole, a benzothiazole derivative. As a nonergot dopamine agonist, pramipexole binds to D2 and D3 dopamine receptors in the striatum and su... |
|
T11011 |
Dexpramipexole dihydrochloride
|
KNS-760704 dihydrochloride,R-(+)-Pramipexole dihydrochloride,(R)-Pramipexole dihydrochloride |
Dopamine Receptor
|
|
Dexpramipexole dihydrochloride (KNS-760704 dihydrochloride) ((R)-Pramipexole dihydrochloride) is a neuroprotective agent and is a weak non-ergoline dopamine agonist. |
|
T1476L |
Pramipexole dihydrochloride
|
|
Dopamine Receptor
|
|
Pramipexole dihydrochloride could be used to treat Parkinson disease. |
|
TQ0175 |
Dexpramipexole
|
R-(+)-Pramipexole,(R)-Pramipexole,KNS-760704 |
Dopamine Receptor
|
|
Dexpramipexole (KNS-760704, R-(+)-Pramipexole) is a neuroprotective agent and weak non-ergoline dopamine agonist. |
